Free Trial
OTCMKTS:REMI

Remedent (REMI) Stock Price, News & Analysis

Remedent logo
$0.05 0.00 (0.00%)
(As of 11/22/2024 ET)

About Remedent Stock (OTCMKTS:REMI)

Key Stats

Today's Range
$0.05
$0.05
50-Day Range
$0.05
$0.06
52-Week Range
$0.00
$0.15
Volume
5,000 shs
Average Volume
2 shs
Market Capitalization
$1 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium.

Receive REMI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Remedent and its competitors with MarketBeat's FREE daily newsletter.

REMI Stock News Headlines

REMYY Rémy Cointreau SA
Download Our Tesla Ebook For Free
Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.
Peterson Remy
Remedent, Inc. (REMI)
See More Headlines

REMI Stock Analysis - Frequently Asked Questions

Remedent's stock was trading at $0.0970 at the beginning of the year. Since then, REMI stock has decreased by 48.5% and is now trading at $0.05.
View the best growth stocks for 2024 here
.

Shares of REMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Remedent investors own include AbbVie (ABBV), CoStar Group (CSGP), Enterprise Products Partners (EPD), Kellanova (K), Kandi Technologies Group (KNDI), MKS Instruments (MKSI) and M&T Bank (MTB).

Company Calendar

Today
11/23/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Dental equipment & supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:REMI
Employees
3
Year Founded
N/A

Profitability

Net Income
$-270,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$990,000.00

Miscellaneous

Free Float
N/A
Market Cap
$1 million
Optionable
Not Optionable
Beta
-0.01

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (OTCMKTS:REMI) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners